Disease/Infection News

RSS

The effects of prolonged sleep restriction on energy intake, energy expenditure, and regional fat storage in healthy individuals

A new study provides insights into how experimentally-induced sleeplessness affects body fat when the subject is provided access to food.

1 Apr 2022

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

Higher avocado intake associated with lower risk of cardiovascular disease and coronary heart disease in US adults

The current study looks at how avocado intake is related to the total CVD, CHD, and stroke risk, using data from two studies, namely, the NHS and the HPFS.

1 Apr 2022

COVID-19 incinerators set new record for merseyside manufacturer

A global waste management specialist has completed its first ever air-freighted incinerator system in record time, to help United Arab Emirates hospitals manage Coronavirus-infected waste.

From Inciner8 Limited 1 Apr 2022

Managing hazardous waste during the Covid-19 pandemic

In a hospital or medical environment, preventing and delaying the spread of Coronavirus goes far beyond washing hands. Good biosecurity is essential, and the safe disposal of infected waste will save lives.

From Inciner8 Limited 1 Apr 2022

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

A new study accepted for publication in the journal Transboundary and Emerging Diseases assesses the potential exposure of U.K. deer to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since studies have shown the spill-over of SARS-CoV-2 infections to the Northern American white-tailed deer. If there is a spill-over, wild deer species can act as reservoirs of SARS-CoV-2 with the possibility of the emergence of new variants.

31 Mar 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

Therapeutic antibodies against filoviruses including Ebola and Marburg

Researchers discuss the development and structural characterization of therapeutic monoclonal antibodies targeting the surface glycoprotein of filoviruses.

31 Mar 2022

Potential new approach could make Japanese encephalitis vaccine more affordable

A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable and increase dose numbers in Australia.

31 Mar 2022

The longest duration of SARS-CoV-2 positivity after initial diagnosis

An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.

31 Mar 2022

The mucosal antibody response to SARS-CoV-2

Researchers determine mucosal SARS-CoV-2-specific antibody levels and their neutralizing effect in pediatric and adult patients.

31 Mar 2022

How effective are household cleaning agents against SARS-CoV-2?

Researchers analyze commonly available household cleaning products to determine the most effective virucidal agent against SARS-CoV-2.

31 Mar 2022

The evolution of the SARS-CoV-2 spike protein

Researchers discuss the evolution and mechanisms of mutations that have occurred in the spike protein of SARS-CoV-2.

31 Mar 2022

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.

31 Mar 2022

UIC researchers projected to receive $22 million to study long COVID-19

A team of University of Illinois Chicago researchers is projected to receive approximately $22 million from the National Institutes of Health over four years to research long COVID-19.

31 Mar 2022

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

A new study has found that the Novaplex SARS-CoV-2 Variant I, II, and IV real-time PCR assays (from Seegene Technology) can reliably detect SARS-CoV-2 in patient samples and identify known variants of interest and concern.

31 Mar 2022

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

We are pleased to announce that the arrangements that were made for the purposes of regulation 13 of the National Health Service (Charges for Drugs and Appliances) Regulations 2015, for antiviral medicines to be supplied for free to patients who have tested positive for COVID-19 and who are eligible to receive antiviral treatments for COVID-19 via Covid Medicines Delivery Units (CMDUs), will be extended until 31st March 2023.

31 Mar 2022

Disease/Infection News

The effects of prolonged sleep restriction on energy intake, energy expenditure, and regional fat storage in healthy individuals

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Higher avocado intake associated with lower risk of cardiovascular disease and coronary heart disease in US adults

COVID-19 incinerators set new record for merseyside manufacturer

Managing hazardous waste during the Covid-19 pandemic

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Therapeutic antibodies against filoviruses including Ebola and Marburg

Potential new approach could make Japanese encephalitis vaccine more affordable

The longest duration of SARS-CoV-2 positivity after initial diagnosis

The mucosal antibody response to SARS-CoV-2

How effective are household cleaning agents against SARS-CoV-2?

The evolution of the SARS-CoV-2 spike protein

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

UIC researchers projected to receive $22 million to study long COVID-19

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News